Pneumococcal conjugate second or third-dose vaccines (PCVc) in Lebanon
Lebanon: Pneumococcal conjugate second or third-dose vaccines (PCVc) was 67.0% in 2025. ◆ Volatile
Latest (2025)
67.0%
Change on year
unchanged
World rank
137th
of 194 countries
All-time high
82.0%
in 2017
All-time low
0.0%
in 2008
Years of data
18
2008–2025
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Lebanon, 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for pneumococcal conjugate second or third-dose vaccines (pcvc) in Lebanon is 67.0%, measured in 2025.
That represents a change of down 9.5% over five years.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) in Lebanon peaked at 82.0% in 2017 and was at its lowest, 0.0%, in 2008.
That places Lebanon 137th out of 194 countries with data for 2025, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Lebanon, year by year
| Year | Value | Change |
|---|---|---|
| 2008 | 0.0% | — |
| 2009 | 0.0% | — |
| 2010 | 0.0% | — |
| 2011 | 0.0% | — |
| 2012 | 0.0% | — |
| 2013 | 0.0% | — |
| 2014 | 0.0% | — |
| 2015 | 0.0% | — |
| 2016 | 0.0% | — |
| 2017 | 82.0% | — |
| 2018 | 82.0% | +0.0% |
| 2019 | 82.0% | +0.0% |
| 2020 | 74.0% | -9.8% |
| 2021 | 67.0% | -9.5% |
| 2022 | 67.0% | +0.0% |
| 2023 | 67.0% | +0.0% |
| 2024 | 67.0% | +0.0% |
| 2025 | 67.0% | +0.0% |
Lebanon compared with similar countries
- Lebanon's 67.0% is below the median for lower middle income countries, which is 84.0%, 80% of the median. (47 countries reporting)
- Lebanon's 67.0% is below the median for Middle East, North Africa, Afghanistan & Pakistan, which is 91.0%, 74% of the median. (23 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 2 |
| 2010s | 24.6% | 0.0% | 82.0% | 10 |
| 2020s | 68.2% | 67.0% | 74.0% | 6 |
Countries ranked near Lebanon
- 134 Mozambique 70.0% compare
- 135 Micronesia (country) 69.0% compare
- 135 Indonesia 69.0% compare
- 138 Romania 66.0% compare
- 138 Nauru 66.0% compare
- 140 South Africa 65.0% compare
More health data for Lebanon
- Un projection of annual infant deaths, annual growth rate -2.12 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.46 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,106 deaths per 1,000 people (2090)
- Number of infants who die before age 1 185 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate 0.5482 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2024)
- Population ages 00-04, female, per capita 0.038 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.209 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2024)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) in Lebanon?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) in Lebanon was 67.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Lebanon?
- The highest recorded value was 82.0% in 2017.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Lebanon?
- The lowest recorded value was 0.0% in 2008.
- How does Lebanon rank for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Lebanon ranks 137th out of 194 countries with data for 2025.
- Where does this Lebanon data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).